Thursday, January 01, 2026 | 07:29 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Ajanta Pharma Ltd / Announcements / BSE

Ajanta Pharma Ltd

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

03:06 PM, 13th Nov 2025

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 13 2025 for Ravi Agrawal trustee Ravi Agrawal Trust

More Ajanta Pharma Ltd Announcements

    View more
    Business Standard
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2026 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon